EyePoint, Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- EyePoint, Inc. stock issued during period, value, new issues for the quarter ending 2026-06-30 was $19.53M.
- EyePoint, Inc. stock issued during period, value, new issues for the quarter ending 2025-12-31 was $166.30M, a 10.24% increase year-over-year.
- EyePoint, Inc. stock issued during period, value, new issues for the quarter ending 2025-09-30 was $6.62M, a 43.88% decline year-over-year.
- EyePoint, Inc. stock issued during period, value, new issues for the quarter ending 2024-12-31 was $150.85M, a 30.12% decline year-over-year.
- EyePoint, Inc. stock issued during period, value, new issues for fiscal 2025 was $172.92M, a 6.31% increase from fiscal 2024.
- EyePoint, Inc. stock issued during period, value, new issues for fiscal 2024 was $162.66M, a 27.84% decline from fiscal 2023.
- EyePoint, Inc. stock issued during period, value, new issues for fiscal 2023 was $225.41M, a 1126935.00% increase from fiscal 2022.
- EyePoint, Inc. stock issued during period, value, new issues for fiscal 2022 was $20.00K.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-06-30 | $19.53M 10-Q · filed 2026-08-05 | |
| 2025-12-31 | $166.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $172.92M 10-K · filed 2026-03-05 |
| 2025-09-30 | $6.62M 10-Q · filed 2025-11-06 | |
| 2024-12-31 | $150.85M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $162.66M 10-K · filed 2026-03-05 |
| 2024-09-30 | $11.79M 10-Q · filed 2025-11-06 | $227.68M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $225.43M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $18.00K 10-Q · filed 2025-05-08 | |
| 2023-12-31 | $215.87M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $225.41M 10-K · filed 2025-03-06 |
| 2023-09-30 | $9.54M 10-Q · filed 2024-11-07 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | $20.00K 10-K · filed 2024-03-08 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | |
| 2022-06-30 | $20.00K 10-Q · filed 2023-08-04 | |
| 2021-09-30 | $10.00K 10-Q · filed 2022-11-04 | $133.56M derived: sum of 4 quarters · filed 2022-11-04 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $138.26M derived: sum of 4 quarters · filed 2022-08-05 |
| 2021-03-31 | $108.40M 10-Q · filed 2022-05-06 | $138.26M derived: sum of 4 quarters · filed 2022-05-06 |
| 2020-12-31 | $25.15M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14 | $49.85M 10-K · filed 2022-03-14 |
| 2020-09-30 | $4.71M 10-Q · filed 2021-11-05 | $26.57M derived: sum of 4 quarters · filed 2021-11-05 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $24.27M derived: sum of 4 quarters · filed 2021-08-06 |
| 2020-03-31 | $19.99M 10-Q · filed 2021-05-05 | $42.62M derived: sum of 4 quarters · filed 2021-05-05 |
| 2019-12-31 | $1.87M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $22.63M 10-K · filed 2021-03-12 |
| 2019-09-30 | $2.41M 10-Q · filed 2020-11-06 | |
| 2019-06-30 | $18.34M 10-Q · filed 2020-08-05 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $47.02M derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | $36.38M 10-Q · filed 2019-08-07 | $47.98M 10-K · filed 2020-03-16 |
| 2018-03-31 | $4.56M 10-Q · filed 2019-05-10 | $17.86M derived: sum of 4 quarters · filed 2020-03-16 |
| 2017-12-31 | $6.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-08 | |
| 2017-09-30 | $963.00K 10-Q · filed 2018-11-09 | |
| 2017-06-30 | $6.25M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $8.40M 10-K · filed 2020-03-16 |
| 2016-06-30 | -$1.00K derived: 10-KT 12 month − 10-Q 9 month · filed 2019-03-18 | $16.50M 10-KT · filed 2019-03-18 |
| 2014-06-30 | -$6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-13 | $18.06M 10-K · filed 2016-09-13 |
| 2014-03-31 | $7.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-14 | $18.06M derived: sum of 4 quarters · filed 2015-09-10 |
| 2013-12-31 | $1.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-02-12 | $11.03M derived: sum of 4 quarters · filed 2015-09-10 |
| 2013-09-30 | $9.94M 10-Q · filed 2013-11-13 | $9.94M derived: sum of 4 quarters · filed 2015-09-10 |
| 2013-06-30 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-10 | $4.67M 10-K · filed 2015-09-10 |
| 2013-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-14 | |
| 2012-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-02-08 | |
| 2012-09-30 | $4.67M 10-Q · filed 2012-11-09 | |
| 2011-06-30 | $10.04M 10-K · filed 2013-09-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |